Integer Holdings Co. (NYSE:ITGR) Stake Boosted by Portside Wealth Group LLC

Portside Wealth Group LLC increased its holdings in Integer Holdings Co. (NYSE:ITGR) by 8.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,396 shares of the medical equipment provider’s stock after purchasing an additional 271 shares during the period. Portside Wealth Group LLC’s holdings in Integer were worth $401,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of ITGR. Lee Danner & Bass Inc. bought a new stake in Integer in the fourth quarter worth $27,000. AdvisorNet Financial Inc bought a new stake in Integer in the first quarter worth $28,000. Sterling Capital Management LLC boosted its holdings in Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 279 shares in the last quarter. Principal Securities Inc. boosted its holdings in Integer by 31.2% in the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 152 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its holdings in Integer by 259.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 737 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 532 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Donald J. Spence sold 14,739 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the transaction, the director now owns 18,781 shares of the company’s stock, valued at $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares of the company’s stock, valued at $5,788,990. This trade represents a 87.82% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 362,434 shares of company stock valued at $44,577,115. Insiders own 2.16% of the company’s stock.

Integer Stock Up 0.4%

Integer stock opened at $122.55 on Wednesday. The firm has a market cap of $4.28 billion, a price-to-earnings ratio of 36.47, a P/E/G ratio of 1.72 and a beta of 0.98. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The firm has a fifty day moving average price of $118.95 and a two-hundred day moving average price of $127.87.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.14 earnings per share. As a group, analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of a number of recent research reports. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a “buy” rating in a report on Friday, April 25th. Raymond James upped their price objective on shares of Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, April 25th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. KeyCorp cut their target price on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Finally, Wall Street Zen raised shares of Integer from a “sell” rating to a “hold” rating in a research report on Monday, May 19th. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Integer currently has an average rating of “Moderate Buy” and a consensus price target of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.